Agenus Inc.
ANTIBODIES AND METHODS OF USE THEREOF
Last updated:
Abstract:
Provided are antibodies that specifically bind to CTLA-4 and/or PD-1 and antagonize CTLA-4 and/or PD-1 function. Also provided are pharmaceutical compositions and kits comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies either alone or in combination.
Status:
Application
Type:
Utility
Filling date:
7 Jun 2019
Issue date:
23 Jan 2020